Evaluate the latest clinical prognostic tools to stratify patients with MDS by risk Assess recent FDA-approvals and clinical trial outcomes for patients with low- to intermediate-risk MDS Integrate treatment approaches that allow patients with MDS to achieve transfusion-independence
- Provider:HMP Education
- Activity Link: https://www.hmpeducation.com/program/2024-gduhem-104
- Start Date: 2024-08-29 05:00:00
- End Date: 2024-08-29 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery
Subscribe
Login
0 Comments
Oldest